Amy Wong - Apexigen Sr Operations
Insider
Amy Wong is Sr Operations of Apexigen
| Age | 57 |
| Phone | 650-931-6236 |
| Web | https://www.apexigen.com |
Apexigen Management Efficiency
The company has return on total asset (ROA) of (0.894) % which means that it has lost $0.894 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.9805) %, meaning that it created substantial loss on money invested by shareholders. Apexigen's management efficiency ratios could be used to measure how well Apexigen manages its routine affairs as well as how well it operates its assets and liabilities.Apexigen currently holds 106 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Apexigen has a current ratio of 1.22, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Apexigen's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MBA MD | Immix Biopharma | 49 | |
| Christine Granfield | Leap Therapeutics | 57 | |
| Keith MD | X4 Pharmaceuticals | 54 | |
| MBA IV | Enveric Biosciences | 68 | |
| Augustine Lawlor | Leap Therapeutics | 68 | |
| Ibrahim MD | Enveric Biosciences | 55 | |
| Renato Skerlj | X4 Pharmaceuticals | N/A | |
| DSc MSE | Immix Biopharma | 75 | |
| Avani Kanubaddi | Enveric Biosciences | 51 | |
| Cynthia Sirard | Leap Therapeutics | 54 | |
| Peter Facchini | Enveric Biosciences | 61 | |
| Arthur Taveras | X4 Pharmaceuticals | 61 | |
| Mark OMahony | Leap Therapeutics | 54 | |
| Gabriel BA | Immix Biopharma | 38 | |
| Walter Newman | Leap Therapeutics | 78 | |
| Murray MD | X4 Pharmaceuticals | 63 | |
| JD MBA | Immix Biopharma | N/A | |
| Dr MedSc | Phio Pharmaceuticals Corp | 68 | |
| Mary DiBiase | X4 Pharmaceuticals | 64 | |
| Nandan BS | Immix Biopharma | 63 | |
| Joseph Tucker | Enveric Biosciences | 56 | |
Management Performance
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 |
Apexigen Leadership Team
Elected by the shareholders, the Apexigen's board of directors comprises two types of representatives: Apexigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apexigen. The board's role is to monitor Apexigen's management team and ensure that shareholders' interests are well served. Apexigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apexigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaodong MD, CEO Pres | ||
| Francis Sarena, Chief Officer | ||
| Frank MD, Chief Officer | ||
| William Duke, Chief Officer | ||
| Jason Wright, VP CMC | ||
| Amy Wong, Sr Operations |
Apexigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apexigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 | |||
| Current Valuation | 205.33 K | |||
| Shares Outstanding | 24.86 M | |||
| Shares Owned By Insiders | 8.81 % | |||
| Shares Owned By Institutions | 13.54 % | |||
| Number Of Shares Shorted | 64.45 K | |||
| Price To Book | 2.32 X | |||
| EBITDA | (32.58 M) | |||
| Net Income | (32.07 M) |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |